Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Current Events' Category

Mid-week Links

Physician spending and malpractice claims. Cancer in rural America. Cost of colon cancer: $6.4 billion. Will Obamacare hurt small business? Traffic relief in LA?

Read the rest of this entry »

Thursday Links

Too much cancer data? L.A. cancer sleuths. Who owns a corporation? Being graded. Medicare won’t let researchers study substance abuse?

Read the rest of this entry »

Friday Links

Who’s to blame: patients or physicians? Doctors as subcontractors. A “miracle” cure for cancer? Extreme study abroad. Cost of obesity: $8 billion. The original Luddite.

Read the rest of this entry »

Wednesday Links

Progress on hospital EHRs. Drugs going off-patent in 2016. Legislation to improve innovation? Marijuana and rent seeking in Ohio. 3D-printed ribs? What are the top 5 health care mergers of 2015?

Read the rest of this entry »

Tuesday Links

Old boys network? Should pregnant women get temporary disability payments? Do economists need social skills? Payday loans aren’t so bad afterall? Medicare at 50.

Read the rest of this entry »

Angus Deaton wins nobel prize in economics

You can find the Nobel website press release here: The work for which Deaton is now being honored revolves around three central questions: How do consumers distribute their spending among different goods?Answering this question is not only necessary for explaining and forecasting actual consumption patterns, but also crucial in evaluating how policy reforms, like changes […]

Read the rest of this entry »

Friday Links

Connect or be replaced. Thoughts on homeschooling. Nudge = spam? Thoughts on BRCA. ACOs success mixed. Is the Ebola epidemic over? Should the government regulate drug prices?

Read the rest of this entry »

Friday Links

Can antidepressants cure cancer? Dieselgate and cancer. New approach to breast cancer “treatment”? What’s all the hype about big data in healthcare? How well do you choose your health plan?

Read the rest of this entry »

“An astonishingly naïve approach”

That was Amitabh Chandra’s comment on Hillary Clinton’s plan to reign in drug prices and I don’t disagree. According to the N.Y. Times, her plan: …includes regulating the percentage of revenues pharmaceutical companies must spend on research and development, instituting a cap on the cost of many out-of-pocket drugs for chronic and serious health conditions, and allocating […]

Read the rest of this entry »

Friday Links

Can aspirin treat cancer? Google + Udacity offer a Nanodegree. On cardiologists? An effective Alzheimer’s treatment? Should athletes be allowed to dope?

Read the rest of this entry »